HPV Screening with Self Collection Endorsed by Three Organizations
Three organizations—ACS, ACOG, and HRSA—have each recently endorsed new guidelines for cervical cancer screening. All of them discuss screening with self collected samples.
New research finds that women in the U.S. are dying from cervical cancer at rates far higher than we realized, especially with black women.
Researchers from Johns Hopkins University examined the mortality rate (or death rate) with cervical cancer and say the statistics are skewed because they include women who have had a total hysterectomy and no longer have a cervix (and no risk for cervical cancer). When looking only at women whose cervix is intact, the investigators found the corrected mortality rate for black women with cervical cancer is actually 10.1 per 100,000 compared to 5.7 per 100,000 with the uncorrected data that includes women who have had a total hysterectomy. For white women, the corrected rate is 4.7 per 100,000 versus an uncorrected rate of 3.2.
Without the corrected figures, the authors say we’re underestimating the true disparity between black and white women by a whopping 44%.
The authors say the racial differences likely stem from a variety of factors: compared to white women, black women have more barriers to health care and tend to be diagnosed with cervical cancer at a more advanced stage of disease (when the outcomes are poorer). They also note that differences in treatment may have a role, as black women with cervical cancer are at greater risk of inadequate care.
The American Cancer Society estimates there are approximately 13,000 total new cases of cervical cancer in the U.S. each year and about 4,000 deaths. ASHA president and CEO Lynn Barclay says the racial disparities are unacceptable and needless. “We have the tools to prevent cervical cancer and let me be clear: not one single woman need die from this disease,” she says. “It is heartbreaking that black women continue to suffer an unfair burden of cervical cancer mortality, and a national embarrassment that we’re not developing and funding programs to make sure the most vulnerable communities get the care they need.”
For more on preventing cervical cancer, including how to raise your voice and get involved, visit NCCC online.
Three organizations—ACS, ACOG, and HRSA—have each recently endorsed new guidelines for cervical cancer screening. All of them discuss screening with self collected samples.
Research suggests that only one dose of the HPV vaccine may be effective enough to prevent HPV-related disease, including cancer.
Australia has been a leader in cervical cancer prevention for decades and is now close to eliminating the disease.
The American Cancer Society (ACS) released new recommendations for cervical cancer screening that focus on HPV testing and approve the use of self-collected samples. The recommendations also clarify the age at which screening should start and stop.
The FDA just approved the Teal Wand, a self-collection device for HPV testing that does not require a speculum exam or even a trip to the doctor’s office. People can collect their own sample at home and send it to a lab for analysis.
The results of large-scale study of HPV suggest that one shot of the vaccine may be enough to protect young people from HPV and related issues like cervical cancer.
ASHA believes that all people have the right to the information and services that will help them to have optimum sexual health. We envision a time when stigma is no longer associated with sexual health and our nation is united in its belief that sexuality is a normal, healthy, and positive aspect of human life.
ABOUT
GET INVOLVED
ASHA WEBSITES
GET HELP
© 2026 American Sexual Health Association
We need to know if we can keep you company during this visit. We are useful for making this site work.